Sophion partners with Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, to enable standardized integration between Sophion APC platforms and Genedata Screener.
Improving the benchmark for cardiac safety with QPatch II automated patch clamp
High throughput screening on ion channels made easy
A case study on how Enterprise Therapeutics successfully applied automated patch clamp in primary screening and lead optimization in its TMEM16A drug discovery programme
Full integration of Qube 384 and QPatch II data to Genedata Screener will ensure that APC data can be analyzed in a screening context, i.e., integrated with molecule and assay property information, scaling from one to hundreds of plates per batch.
Sophion Japan collaborated with Toho University on Oseltamivir an anti-afibrillatory; a review of APC in cardiac safety assessment.
Ion channels are involved in both initiating and transmitting pain
Ion channels are key in drug safety studies and important target for many heart diseases
Evidence suggest that ion channels play a key role in psychiatric diseases
Ion channels play an emerging role as potential drugable targets for cancer treatments
Read more about other disease areas driven by ion channel malfunction